NO132761B - - Google Patents
Download PDFInfo
- Publication number
- NO132761B NO132761B NO3013/72A NO301372A NO132761B NO 132761 B NO132761 B NO 132761B NO 3013/72 A NO3013/72 A NO 3013/72A NO 301372 A NO301372 A NO 301372A NO 132761 B NO132761 B NO 132761B
- Authority
- NO
- Norway
- Prior art keywords
- acid
- general formula
- ethanol
- filtered
- preparation
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 16
- 239000002253 acid Substances 0.000 claims description 15
- 150000002148 esters Chemical class 0.000 claims description 14
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims description 12
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 9
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 7
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 6
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 claims description 6
- 235000019253 formic acid Nutrition 0.000 claims description 6
- 229940098779 methanesulfonic acid Drugs 0.000 claims description 6
- 239000005751 Copper oxide Substances 0.000 claims description 5
- 229910000431 copper oxide Inorganic materials 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 239000001257 hydrogen Substances 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 claims description 3
- 238000011065 in-situ storage Methods 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 238000010992 reflux Methods 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 37
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 26
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 18
- 238000002360 preparation method Methods 0.000 description 17
- 238000002844 melting Methods 0.000 description 13
- 230000008018 melting Effects 0.000 description 13
- 229910052757 nitrogen Inorganic materials 0.000 description 13
- 239000000047 product Substances 0.000 description 13
- 239000000243 solution Substances 0.000 description 13
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- REGFWZVTTFGQOJ-UHFFFAOYSA-N 4,5-dihydro-1,3-thiazol-2-amine Chemical compound NC1=NCCS1 REGFWZVTTFGQOJ-UHFFFAOYSA-N 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 239000000463 material Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 230000000202 analgesic effect Effects 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- 239000000956 alloy Substances 0.000 description 4
- 229910045601 alloy Inorganic materials 0.000 description 4
- LTMHNWPUDSTBKD-UHFFFAOYSA-N diethyl 2-(ethoxymethylidene)propanedioate Chemical compound CCOC=C(C(=O)OCC)C(=O)OCC LTMHNWPUDSTBKD-UHFFFAOYSA-N 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 230000001476 alcoholic effect Effects 0.000 description 3
- IOJUPLGTWVMSFF-UHFFFAOYSA-N cyclobenzothiazole Natural products C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- -1 2-aminohexahydrobenzothiazole hydrochloride Chemical compound 0.000 description 1
- KYUNTDRHCPSMOG-UHFFFAOYSA-N 2h-1,3-benzothiazole-3-carboxylic acid Chemical compound C1=CC=C2N(C(=O)O)CSC2=C1 KYUNTDRHCPSMOG-UHFFFAOYSA-N 0.000 description 1
- SILRNKZBMNSABG-UHFFFAOYSA-N 4-methyl-4,5-dihydro-1,3-thiazol-2-amine Chemical compound CC1CSC(N)=N1 SILRNKZBMNSABG-UHFFFAOYSA-N 0.000 description 1
- IKFLLHVVKJTHAH-UHFFFAOYSA-N 5-methyl-4,5-dihydro-1,3-thiazol-2-amine Chemical compound CC1CN=C(N)S1 IKFLLHVVKJTHAH-UHFFFAOYSA-N 0.000 description 1
- LYVYJEYHYALPFP-UHFFFAOYSA-N Cl.N=C1SC(CN1)C1=CC=CC=C1 Chemical compound Cl.N=C1SC(CN1)C1=CC=CC=C1 LYVYJEYHYALPFP-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 239000001358 L(+)-tartaric acid Substances 0.000 description 1
- 235000011002 L(+)-tartaric acid Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-LWMBPPNESA-N L-(+)-Tartaric acid Natural products OC(=O)[C@@H](O)[C@H](O)C(O)=O FEWJPZIEWOKRBE-LWMBPPNESA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241000219422 Urtica Species 0.000 description 1
- 235000009108 Urtica dioica Nutrition 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- XTLNYNMNUCLWEZ-UHFFFAOYSA-N ethanol;propan-2-one Chemical compound CCO.CC(C)=O XTLNYNMNUCLWEZ-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB3958571A GB1374281A (en) | 1971-08-24 | 1971-08-24 | Thiazolino-pyrimidin-5-one derivatives process for their pre paration and applications thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO132761B true NO132761B (fr) | 1975-09-22 |
| NO132761C NO132761C (fr) | 1975-12-29 |
Family
ID=10410359
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO3013/72A NO132761C (fr) | 1971-08-24 | 1972-08-23 |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US3876639A (fr) |
| JP (1) | JPS5518718B2 (fr) |
| AR (1) | AR204501A1 (fr) |
| AT (1) | AT318626B (fr) |
| BE (1) | BE787307A (fr) |
| CA (1) | CA962677A (fr) |
| CH (1) | CH540286A (fr) |
| DE (2) | DE2241241C3 (fr) |
| DK (1) | DK131470B (fr) |
| ES (1) | ES406367A1 (fr) |
| FR (1) | FR2150762B1 (fr) |
| GB (1) | GB1374281A (fr) |
| IE (1) | IE36874B1 (fr) |
| IL (1) | IL40133A (fr) |
| LU (1) | LU65936A1 (fr) |
| NL (1) | NL149082B (fr) |
| NO (1) | NO132761C (fr) |
| OA (1) | OA04261A (fr) |
| SE (1) | SE378599B (fr) |
| ZA (1) | ZA725626B (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4535081A (en) * | 1979-11-23 | 1985-08-13 | Pfizer Inc. | Antiallergic and antiulcer 1-oxo-1H-thiazolo[3,2-a]pyrimidine-2-carboxamides and intermediates therefor |
| US4443451A (en) * | 1981-07-15 | 1984-04-17 | Janssen Pharmaceutica N.V. | Bicyclic pyrimidin-5-one derivatives |
| US4562058A (en) * | 1983-08-02 | 1985-12-31 | International Minerals & Chemical Corp. | Process for crystallizing potassium sulfate |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH491944A (de) * | 1966-11-29 | 1970-06-15 | Ciba Geigy | Verfahren zur Herstellung von benzheterocyclischen Verbindungen |
-
1971
- 1971-08-24 GB GB3958571A patent/GB1374281A/en not_active Expired
-
1972
- 1972-01-01 AR AR243711A patent/AR204501A1/es active
- 1972-08-07 CH CH1165672A patent/CH540286A/fr not_active IP Right Cessation
- 1972-08-08 BE BE787307A patent/BE787307A/fr unknown
- 1972-08-10 FR FR7228951A patent/FR2150762B1/fr not_active Expired
- 1972-08-14 US US280165A patent/US3876639A/en not_active Expired - Lifetime
- 1972-08-15 IE IE1132/72A patent/IE36874B1/xx unknown
- 1972-08-15 IL IL40133A patent/IL40133A/xx unknown
- 1972-08-16 ZA ZA725626A patent/ZA725626B/xx unknown
- 1972-08-21 JP JP8288772A patent/JPS5518718B2/ja not_active Expired
- 1972-08-21 DK DK413472AA patent/DK131470B/da unknown
- 1972-08-22 LU LU65936A patent/LU65936A1/xx unknown
- 1972-08-22 DE DE19722241241 patent/DE2241241C3/de not_active Expired
- 1972-08-22 CA CA149,965A patent/CA962677A/en not_active Expired
- 1972-08-22 NL NL727211463A patent/NL149082B/xx not_active IP Right Cessation
- 1972-08-22 DE DE2264979A patent/DE2264979C3/de not_active Expired
- 1972-08-23 SE SE7210922A patent/SE378599B/xx unknown
- 1972-08-23 AT AT728172A patent/AT318626B/de not_active IP Right Cessation
- 1972-08-23 NO NO3013/72A patent/NO132761C/no unknown
- 1972-08-23 ES ES406367A patent/ES406367A1/es not_active Expired
- 1972-08-23 OA OA54671A patent/OA04261A/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NL7211463A (fr) | 1973-02-27 |
| JPS4848493A (fr) | 1973-07-09 |
| AR204501A1 (es) | 1976-02-12 |
| ZA725626B (en) | 1973-05-30 |
| NL149082B (nl) | 1976-04-15 |
| OA04261A (fr) | 1979-12-31 |
| CH540286A (fr) | 1973-08-15 |
| FR2150762A1 (fr) | 1973-04-13 |
| IL40133A (en) | 1975-03-13 |
| CA962677A (en) | 1975-02-11 |
| DE2264979C3 (de) | 1981-12-03 |
| LU65936A1 (fr) | 1973-01-15 |
| GB1374281A (en) | 1974-11-20 |
| ES406367A1 (es) | 1975-07-01 |
| DE2241241B2 (de) | 1977-06-02 |
| BE787307A (fr) | 1972-12-01 |
| SE378599B (fr) | 1975-09-08 |
| DK131470B (da) | 1975-07-21 |
| AT318626B (de) | 1974-11-11 |
| IE36874B1 (en) | 1977-03-16 |
| DK131470C (fr) | 1975-12-08 |
| FR2150762B1 (fr) | 1976-04-16 |
| DE2241241A1 (de) | 1973-03-15 |
| DE2241241C3 (de) | 1978-01-19 |
| DE2264979A1 (de) | 1976-01-15 |
| IL40133A0 (en) | 1972-10-29 |
| DE2264979B2 (de) | 1981-02-26 |
| NO132761C (fr) | 1975-12-29 |
| IE36874L (en) | 1973-02-24 |
| US3876639A (en) | 1975-04-08 |
| JPS5518718B2 (fr) | 1980-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2556821B2 (ja) | 三環式芳香族化合物 | |
| US4110337A (en) | Triazolobenzodiazepines | |
| CA1113114A (fr) | Derives de l'acide cycloalkylidenemethylphenylacetique | |
| NO874834L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridinoner. | |
| US4299831A (en) | 2-Trifluoromethyl-3-quinoline carboxamides, analgesic and anti-inflammatory compositions and methods employing them | |
| NO884008L (no) | Fremgangsmaate for fremstilling av 3,7-diazabicyclo(3,3,1)nonanforbindelser. | |
| HU186523B (en) | Process for producing quinoline derivatives | |
| US2489236A (en) | Synthesis of biotin and related compounds | |
| NO147564B (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 5-benzyol-1,2-dihydro-3h-pyrrolo(1,2-a)pyrrol-1-karboksylsyrederivater | |
| NO132761B (fr) | ||
| Smith Jr et al. | α-Aminophenacylpyridines and Quinolines1 | |
| Cannon et al. | Congeners of the. alpha. conformer of dopamine derived from octahydrobenz [h] isoquinoline | |
| US4127720A (en) | Pyrimido[2,1-a]isoquinoline derivatives having antiallergy activity | |
| US3306909A (en) | 3-carbamoyl-1,5-diphenyl-2,4-pyrrolidinediones | |
| US3627763A (en) | Substituted 2-benzyl-benzofuran derivatives | |
| US3972994A (en) | Disubstituted azabicycloalkanes | |
| US4116972A (en) | Anti-inflammatory 1-oxo-isoindoline derivatives and processes for their preparation | |
| US4232160A (en) | Isoquinoline propionamides exhibiting analgesic properties | |
| US4576953A (en) | Quinoline derivatives | |
| US4267331A (en) | Process for the production of 2-substituted pyrido[4,3-b]-indoles | |
| EP0011206B1 (fr) | 9,10-Dihydro-4H-benzo(4,5)cyclohepta(1,2-b)thiophèn-4,9-imines, procédé pour leur préparation et compositions pharmaceutiques les contenant | |
| US3743659A (en) | Substituted isochromans and processes therefor | |
| NO751401L (fr) | ||
| US4033970A (en) | Various 1,5,10,11-tetrahydrobenzo [4,5]-cyclohepta [1,2-b]pyrazolo[4,3-e]pyridine derivatives | |
| NO149387B (no) | Fremgangsmaate til fremstilling av 6,11-dihydro-11-oksodibenz(b,e)-oksepinalkansyrer |